BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 21756858)

  • 1. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.
    Wang JH; Wang CC; Hung CH; Chen CL; Lu SN
    J Hepatol; 2012 Feb; 56(2):412-8. PubMed ID: 21756858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
    Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
    Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma.
    Wong KM; Yeh ML; Chuang SC; Wang LY; Lin ZY; Chen SC; Tsai JF; Wang SN; Kuo KK; Dai CY; Yu ML; Lee KT; Chuang WL
    Indian J Gastroenterol; 2013 Jul; 32(4):253-7. PubMed ID: 22932964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
    BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.
    Takuma Y; Takabatake H; Morimoto Y; Toshikuni N; Kayahara T; Makino Y; Yamamoto H
    Radiology; 2013 Dec; 269(3):927-37. PubMed ID: 24086071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
    Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients.
    Hocquelet A; Balageas P; Laurent C; Blanc JF; Frulio N; Salut C; Cassinotto C; Saric J; Possenti L; Bernard PH; Montaudon M; Trillaud H
    Int J Hyperthermia; 2015; 31(7):749-57. PubMed ID: 26365503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
    Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI
    Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
    Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
    Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Outcomes of Hepatic Resection and Radiofrequency Ablation for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the Barcelona-Clinic Liver Cancer Stage A Classification.
    Jiang L; Yan L; Wen T; Li B; Zeng Y; Yang J; Wang W; Xu M; Wu H
    J Am Coll Surg; 2015 Nov; 221(5):951-61. PubMed ID: 26362135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous radiofrequency ablation therapy for recurrent hepatocellular carcinoma.
    Nishikawa H; Osaki Y; Iguchi E; Takeda H; Ohara Y; Sakamoto A; Hatamaru K; Saito S; Nasu A; Kita R; Kimura T
    Anticancer Res; 2012 Nov; 32(11):5059-65. PubMed ID: 23155279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.
    Feng K; Yan J; Li X; Xia F; Ma K; Wang S; Bie P; Dong J
    J Hepatol; 2012 Oct; 57(4):794-802. PubMed ID: 22634125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis.
    Torzilli G; Donadon M; Marconi M; Palmisano A; Del Fabbro D; Spinelli A; Botea F; Montorsi M
    Arch Surg; 2008 Nov; 143(11):1082-90. PubMed ID: 19015467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study.
    Hsiao CY; Hu RH; Ho CM; Wu YM; Lee PH; Ho MC
    Am J Surg; 2020 Oct; 220(4):958-964. PubMed ID: 32247523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.
    Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T
    J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analyses.
    Lee YH; Hsu CY; Chu CW; Liu PH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
    J Clin Gastroenterol; 2015 Mar; 49(3):242-9. PubMed ID: 24714185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.